Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Paschalaki, A. Mulgirigama, S. Papiris, P. J. Barnes, S. A. Kharitonov (London, United Kingdom; Athens, Greece). Multiple detectable exhaled volatile organic compounds (vocs) may serve as potential inflammatory biomarkers in COPD. Eur Respir J 2009; 34: Suppl. 53, 3158

Member's Comments

ZANEN Pieter - 15.09.2009 10:10
comparison of results
hello we have PTR-MS data in close to 300 heavy smokers with/without obstruction and/or emphysema. It would be nice to discuss/compare data, methods etc. My name is pieter zanen from the University Medical Centre Utrecht, the Netherlands. E-mail: p.zanen@umcutrecht.nl thnaks and hope to hear from you

Related content which might interest you: Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD Source: Eur Respir J 2011; 38: 1301-1309 Year: 2011 Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function Source: International Congress 2015 – The next generation of lung function tests Year: 2015 Volatile organic compounds (VOC) in exhaled breath of patients with COPD Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Value of exhaled volatile organic compounds in monitoring airway disease Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Volatile organic compounds (VOCs) in exhaled air of patients with lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 208s Year: 2003 Exhaled volatile organic compounds as markers for medication use in asthma Source: Eur Respir J, 55 (2) 1900544; 10.1183/13993003.00544-2019 Year: 2020 Volatile organic compounds in COPD: Is hexanal an inflammation biomarker? Source: International Congress 2016 – The future of lung function is beginning now Year: 2016 Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Volatile organic compounds (VOCs) in COPD patients with exacerbation Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Exhaled volatile organic compounds in nonrespiratory diseases Source: Eur Respir Monogr 2010; 49: 140-151 Year: 2010 Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Standardization of exhaled volatile organic compounds (VOCs) measurement Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Alcohol metabolites are detectable in exhaled breath of healthy, unaffected by a breath holding maneuver and may serve as novel pro-inflammatory biomarkers in asthma and COPD Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008 Diet and alcohol affect exhaled volatile organic compounds (VOCs) Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Detection of angiogenesis, antiangiogenesis and hypoxia related molecules in plasma and exhaled breath condensate (EBC): evaluation of potential biomarkers Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 Exhaled volatile organic compounds in idiopathic pulmonary fibrosis and disease progression Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis Year: 2020